Corrigendum to “Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study” [The Journal of Prevention of Alzheimer's Disease 2024;11(3):567–581]
Benoît Souchet(AGCO (Netherlands)), Jérôme Braudeau, Alkéos Michaïl, C Pech, Kimiko Domoto‐Reilly(Massachusetts General Hospital), Colin L. Masters(Mental Health Research Institute), Suman Jayadev(University of Washington), Cristopher Fowler(Florey Institute of Neuroscience and Mental Health), Antoine Berthemy, Baptiste Billoir(Pierre Fabre (France)), Aude Dupuy‐Gayral(Evotec (United States)), Maud Heuillet, François Autelitano(Evotec (Germany)), T Rabowski(University of Washington), Eloi Haudebourg(Evotec (United States))
Cited by 0
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Alzheimer's disease
|Nature Reviews Disease Primers|2015|1.8k
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein
|Proceedings of the National Academy of Sciences|2005|659